ClinicalTrials.gov
public full text
Public Domain
TBR-760 in Adult Patients With Non-Functioning Pituitary Adenomas
This is a randomized, double-blind, placebo-controlled study to assess the safety, tolerability, efficacy, PK, and PD of the chimeric dopamine-somatostatin receptor agonist, TBR-760, in adult patients with NFPA over 52 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors#1057943
- Short and Long Term Efficacy of Combined Cabergoline and Octreotide Treatment in Acromegalic Patients#853931
- Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients#854738
- Safety and Tolerability Trial of Psilocybin in Healthy Older Adults#825546
- Recombinant Human Growth Hormone During Rehabilitation From Traumatic Brain Injury.#858464
Record · ID 880258
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive